1
|
Chauhan A, Alam MA, Kaur A, Malviya R. Advancements and Utilizations of Scaffolds in Tissue Engineering and Drug Delivery. Curr Drug Targets 2023; 24:13-40. [PMID: 36221880 DOI: 10.2174/1389450123666221011100235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2022] [Revised: 03/02/2022] [Accepted: 03/09/2022] [Indexed: 11/22/2022]
Abstract
The drug development process requires a thorough understanding of the scaffold and its three-dimensional structure. Scaffolding is a technique for tissue engineering and the formation of contemporary functioning tissues. Tissue engineering is sometimes referred to as regenerative medicine. They also ensure that drugs are delivered with precision. Information regarding scaffolding techniques, scaffolding kinds, and other relevant facts, such as 3D nanostructuring, are discussed in depth in this literature. They are specific and demonstrate localized action for a specific reason. Scaffold's acquisition nature and flexibility make it a new drug delivery technology with good availability and structural parameter management.
Collapse
Affiliation(s)
- Akash Chauhan
- Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India
| | - Md Aftab Alam
- Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India
| | - Awaneet Kaur
- Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India
| | - Rishabha Malviya
- Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India
| |
Collapse
|
2
|
Dhamecha D, Le D, Movsas R, Gonsalves A, Menon JU. Porous Polymeric Microspheres With Controllable Pore Diameters for Tissue Engineered Lung Tumor Model Development. Front Bioeng Biotechnol 2020; 8:799. [PMID: 32754585 PMCID: PMC7365955 DOI: 10.3389/fbioe.2020.00799] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2020] [Accepted: 06/22/2020] [Indexed: 12/15/2022] Open
Abstract
Complex cell cultures are more representative of in vivo conditions than conventionally used monolayer cultures, and are hence being investigated for predictive screening of therapeutic agents. Poly lactide co-glycolide (PLGA) polymer is frequently used in the development of porous substrates for complex cell culture. Substrates or scaffolds with highly interconnected, micrometric pores have been shown to positively impact tissue model formation by enhancing cell attachment and infiltration. We report a novel alginate microsphere (AMS)-based controlled pore formation method for the development of porous, biodegradable PLGA microspheres (PPMS), for tissue engineered lung tumor model development. The AMS porogen, non-porous PLGA microspheres (PLGAMS) and PPMS had spherical morphology (mean diameters: 10.3 ± 4, 79 ± 21.8, and 103 ± 30 μm, respectively). The PPMS had relatively uniform pores and a porosity of 45.5%. Degradation studies show that PPMS effectively maintained their structural integrity with time whereas PLGAMS showed shrunken morphology. The optimized cell seeding density on PPMS was 25 × 103 cells/mg of particles/well. Collagen coating on PPMS significantly enhanced the attachment and proliferation of co-cultures of A549 lung adenocarcinoma and MRC-5 lung fibroblast cells. Preliminary proof-of-concept drug screening studies using mono- and combination anti-cancer therapies demonstrated that the tissue-engineered lung tumor model had a significantly higher resistance to the tested drugs than the monolayer co-cultures. These studies indicate that the PPMS with controllable pore diameters may be a suitable platform for the development of complex tumor cultures for early in vitro drug screening applications.
Collapse
Affiliation(s)
| | | | | | | | - Jyothi U. Menon
- Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, United States
| |
Collapse
|
3
|
Krieghoff J, Picke AK, Salbach-Hirsch J, Rother S, Heinemann C, Bernhardt R, Kascholke C, Möller S, Rauner M, Schnabelrauch M, Hintze V, Scharnweber D, Schulz-Siegmund M, Hacker MC, Hofbauer LC, Hofbauer C. Increased pore size of scaffolds improves coating efficiency with sulfated hyaluronan and mineralization capacity of osteoblasts. Biomater Res 2019; 23:26. [PMID: 31890268 PMCID: PMC6921484 DOI: 10.1186/s40824-019-0172-z] [Citation(s) in RCA: 31] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2019] [Accepted: 11/13/2019] [Indexed: 12/13/2022] Open
Abstract
Background Delayed bone regeneration of fractures in osteoporosis patients or of critical-size bone defects after tumor resection are a major medical and socio-economic challenge. Therefore, the development of more effective and osteoinductive biomaterials is crucial. Methods We examined the osteogenic potential of macroporous scaffolds with varying pore sizes after biofunctionalization with a collagen/high-sulfated hyaluronan (sHA3) coating in vitro. The three-dimensional scaffolds were made up from a biodegradable three-armed lactic acid-based macromer (TriLA) by cross-polymerization. Templating with solid lipid particles that melt during fabrication generates a continuous pore network. Human mesenchymal stem cells (hMSC) cultivated on the functionalized scaffolds in vitro were investigated for cell viability, production of alkaline phosphatase (ALP) and bone matrix formation. Statistical analysis was performed using student’s t-test or two-way ANOVA. Results We succeeded in generating scaffolds that feature a significantly higher average pore size and a broader distribution of individual pore sizes (HiPo) by modifying composition and relative amount of lipid particles, macromer concentration and temperature for cross-polymerization during scaffold fabrication. Overall porosity was retained, while the scaffolds showed a 25% decrease in compressive modulus compared to the initial TriLA scaffolds with a lower pore size (LoPo). These HiPo scaffolds were more readily coated as shown by higher amounts of immobilized collagen (+ 44%) and sHA3 (+ 25%) compared to LoPo scaffolds. In vitro, culture of hMSCs on collagen and/or sHA3-coated HiPo scaffolds demonstrated unaltered cell viability. Furthermore, the production of ALP, an early marker of osteogenesis (+ 3-fold), and formation of new bone matrix (+ 2.5-fold) was enhanced by the functionalization with sHA3 of both scaffold types. Nevertheless, effects were more pronounced on HiPo scaffolds about 112%. Conclusion In summary, we showed that the improvement of scaffold pore sizes enhanced the coating efficiency with collagen and sHA3, which had a significant positive effect on bone formation markers, underlining the promise of using this material approach for in vivo studies.
Collapse
Affiliation(s)
- Jan Krieghoff
- 1Institute for Pharmacy, Pharmaceutical Technology, University Leipzig, Leipzig, Germany
| | - Ann-Kristin Picke
- 2Division of Endocrinology, Diabetes, and Metabolic Bone Diseases, Department of Medicine III, Technische Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany.,3Center for Healthy Aging, TU Dresden Medical Center, Dresden, Germany
| | - Juliane Salbach-Hirsch
- 2Division of Endocrinology, Diabetes, and Metabolic Bone Diseases, Department of Medicine III, Technische Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany.,3Center for Healthy Aging, TU Dresden Medical Center, Dresden, Germany
| | - Sandra Rother
- 4Institute of Materials Science, Max Bergmann Center of Biomaterials, Technische Universität Dresden, Dresden, Germany.,Present address: Department of Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, CA USA
| | - Christiane Heinemann
- 4Institute of Materials Science, Max Bergmann Center of Biomaterials, Technische Universität Dresden, Dresden, Germany
| | - Ricardo Bernhardt
- 4Institute of Materials Science, Max Bergmann Center of Biomaterials, Technische Universität Dresden, Dresden, Germany.,6Leibniz Institute of Polymer Research Dresden, Dresden, Germany
| | - Christian Kascholke
- 1Institute for Pharmacy, Pharmaceutical Technology, University Leipzig, Leipzig, Germany
| | | | - Martina Rauner
- 2Division of Endocrinology, Diabetes, and Metabolic Bone Diseases, Department of Medicine III, Technische Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany.,3Center for Healthy Aging, TU Dresden Medical Center, Dresden, Germany
| | | | - Vera Hintze
- 4Institute of Materials Science, Max Bergmann Center of Biomaterials, Technische Universität Dresden, Dresden, Germany
| | - Dieter Scharnweber
- 4Institute of Materials Science, Max Bergmann Center of Biomaterials, Technische Universität Dresden, Dresden, Germany
| | | | - Michael C Hacker
- 1Institute for Pharmacy, Pharmaceutical Technology, University Leipzig, Leipzig, Germany
| | - Lorenz C Hofbauer
- 2Division of Endocrinology, Diabetes, and Metabolic Bone Diseases, Department of Medicine III, Technische Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany.,3Center for Healthy Aging, TU Dresden Medical Center, Dresden, Germany.,8Center for Regenerative Therapies, Dresden, Germany
| | - Christine Hofbauer
- 9Orthopedics and Trauma Surgery Center, Technische Universität Dresden, Dresden, Germany
| |
Collapse
|
4
|
Babaei M, Ghaee A, Nourmohammadi J. Poly (sodium 4-styrene sulfonate)-modified hydroxyapatite nanoparticles in zein-based scaffold as a drug carrier for vancomycin. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2019; 100:874-885. [DOI: 10.1016/j.msec.2019.03.055] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/17/2018] [Revised: 03/02/2019] [Accepted: 03/17/2019] [Indexed: 12/21/2022]
|
5
|
Ratheesh G, Venugopal JR, Chinappan A, Ezhilarasu H, Sadiq A, Ramakrishna S. 3D Fabrication of Polymeric Scaffolds for Regenerative Therapy. ACS Biomater Sci Eng 2017; 3:1175-1194. [PMID: 33440508 DOI: 10.1021/acsbiomaterials.6b00370] [Citation(s) in RCA: 85] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Recent advances in bioprinting technology have been used to precisely dispense cell-laden biomaterials for the construction of complex 3D functional living tissues or artificial organs. Organ printing and biofabrication provides great potential for the freeform fabrication of 3D living organs using cellular spheroids, biocomposite nanofibers, or bioinks as building blocks for regenerative therapy. Vascularization is often identified as a main technological barrier for building 3D organs in tissue engineering. 3D printing of living tissues starts with potential support of biomaterials to maintain structural integrity and degradation of certain time periods after printing of the scaffolds. Biofabrication is the production of complex living and nonliving biological products from raw materials such as cells, molecules, ECM, and biomaterials. Generally, two basic methods are used for the fabrication of scaffolds such as conventional/traditional fabrication processes and advance fabrication processes for engineering organs. A wide range of polymers and biomaterials are used for the fabrication of scaffolds in tissue engineering applications. 3D additive manufacturing is advancing day-by-day; however, there are various critical challenging factors used for fabricating 3D scaffolds. This review is aimed at understanding the various scaffold fabrication techniques, types of polymers and biomaterials used for the fabrication processes, various fields of applications, and different challenges faced in their fabrication of scaffolds in regenerative therapy.
Collapse
Affiliation(s)
- Greeshma Ratheesh
- Center for Nanofibers & Nanotechnology, Department of Mechanical Engineering, National University of Singapore, Singapore 117576.,Science and Engineering Faculty, Queensland University of Technology, Brisbane, Australia
| | - Jayarama Reddy Venugopal
- Center for Nanofibers & Nanotechnology, Department of Mechanical Engineering, National University of Singapore, Singapore 117576
| | - Amutha Chinappan
- Center for Nanofibers & Nanotechnology, Department of Mechanical Engineering, National University of Singapore, Singapore 117576
| | - Hariharan Ezhilarasu
- Center for Nanofibers & Nanotechnology, Department of Mechanical Engineering, National University of Singapore, Singapore 117576
| | - Asif Sadiq
- Center for Nanofibers & Nanotechnology, Department of Mechanical Engineering, National University of Singapore, Singapore 117576
| | - Seeram Ramakrishna
- Center for Nanofibers & Nanotechnology, Department of Mechanical Engineering, National University of Singapore, Singapore 117576.,Guangdong-Hongkong-Macau Institute of CNS Regeneration (GHMICR), Jinan University, Guangzhou 510632, China
| |
Collapse
|
6
|
Loth R, Loth T, Schwabe K, Bernhardt R, Schulz-Siegmund M, Hacker MC. Highly adjustable biomaterial networks from three-armed biodegradable macromers. Acta Biomater 2015; 26:82-96. [PMID: 26277378 DOI: 10.1016/j.actbio.2015.08.008] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2015] [Revised: 07/30/2015] [Accepted: 08/11/2015] [Indexed: 12/01/2022]
Abstract
Biocompatible material platforms with adjustable properties and option for chemical modification are warranted for site-specific biomedical applications. To this end, three-armed biodegradable macromers of well-defined chemical characteristics were prepared from trivalent alcohols with different degrees of ethoxylation and different lengths of oligoester domains. A platform of 15 different macromers was established. The macromers were designed to exhibit different hydrophilicities and molecular weights and contained various types of oligoesters such as d,l-lactide, l-lactide and ε-caprolactone. Macromers chemical composition was determined and molecular weights ranged from 900 to 3000 Da. Thermally induced cross-linking of methacrylated macromers was monitored by oscillation rheology. A novel variant of the solid lipid templating technique was established to fabricate macroporous tissue engineering scaffolds from these macromers. Scaffold properties were thoroughly investigated regarding mechanical properties, compositional analysis including methacrylic double bond conversion, microstructure and porosity. Material properties could be controlled by macromer chemistry. By variation of the fabrication procedure and processing parameters scaffold porosity was increased up to 88%. Basic cytocompatibility was assessed including indirect and direct contact methods. The established macromers hold promise for various biomedical purposes. STATEMENT OF SIGNIFICANCE Specific biomedical applications require tailored biomaterials with defined properties. We established a macromer platform for preparation of tissue engineering scaffolds with adjustable chemical and mechanical characteristics. Macromers were composed of trivalent core alcohols with different degrees of ethoxylation to which biodegradable domains - lactide or ε-caprolactone - were oligomerized before final methacrylation. The solid lipid templating technique was adapted to fabricate macroporous scaffolds with controlled pore structure and porosity from the developed macromers, which can also be processed by solid freeform fabrication techniques. The material platform relies on clinically established chemistries of the biodegradable domains and the macromer concept enables the fabrication of networks in which cross-polymerization kinetics, mechanical properties and surface hydrophobicity is predefined by macromer chemistry. Cytocompatibility was confirmed by indirect and direct cell contact experiments.
Collapse
Affiliation(s)
- Rudi Loth
- Institute of Pharmacy, Pharmaceutical Technology, Leipzig University, Eilenburger Str. 15a, D-04317 Leipzig, Germany; Collaborative Research Center (SFB/Transregio 67), Matrixengineering, Leipzig and Dresden, Germany
| | - Tina Loth
- Institute of Pharmacy, Pharmaceutical Technology, Leipzig University, Eilenburger Str. 15a, D-04317 Leipzig, Germany; Collaborative Research Center (SFB/Transregio 67), Matrixengineering, Leipzig and Dresden, Germany
| | - Katharina Schwabe
- Institute of Pharmacy, Pharmaceutical Technology, Leipzig University, Eilenburger Str. 15a, D-04317 Leipzig, Germany; Collaborative Research Center (SFB/Transregio 67), Matrixengineering, Leipzig and Dresden, Germany
| | - Ricardo Bernhardt
- Max-Bergmann-Center of Biomaterials, Dresden, University of Technology, Budapester Str. 27, D-01062 Dresden, Germany; Collaborative Research Center (SFB/Transregio 67), Matrixengineering, Leipzig and Dresden, Germany
| | - Michaela Schulz-Siegmund
- Institute of Pharmacy, Pharmaceutical Technology, Leipzig University, Eilenburger Str. 15a, D-04317 Leipzig, Germany; Collaborative Research Center (SFB/Transregio 67), Matrixengineering, Leipzig and Dresden, Germany
| | - Michael C Hacker
- Institute of Pharmacy, Pharmaceutical Technology, Leipzig University, Eilenburger Str. 15a, D-04317 Leipzig, Germany; Collaborative Research Center (SFB/Transregio 67), Matrixengineering, Leipzig and Dresden, Germany.
| |
Collapse
|
7
|
GOLUNOVA A, JAROŠ J, JURTÍKOVÁ V, KOTELNIKOV I, KOTEK J, HLÍDKOVÁ H, STREIT L, HAMPL A, RYPÁČEK F, PROKS V. N-(2-Hydroxypropyl) Methacrylamide Based Cryogels – Synthesis and Biomimetic Modification for Stem Cell Applications. Physiol Res 2015; 64:S19-27. [DOI: 10.33549/physiolres.933134] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
The design of favorable mechanical properties and suitable surface modifications of hydrogels in order to stimulate specific cell response is a great challenge. N-(2-Hydroxypropyl) methacryl-amide (HPMA) was utilized to form macroporous cryogel scaffolds for stem cell applications. Furthermore, one group of scaffolds was enhanced by copolymerization of HPMA with methacryloyl-GGGRGDS-OH peptide in an effort to integrate biomimetic adhesion sites. The cryogels were characterized by stiffness and equilibrium swelling measurements as well as by scanning electron microscopy. Cell culture experiments were performed with human adipose-derived stem cells and substrates were found completely non-toxic. Moreover, RGDS-enriched cryogels supported cell attachment, spreading and proliferation, so they can be considered suitable for designed aims.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | - V. PROKS
- Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| |
Collapse
|
8
|
van der Smissen A, Hoffmeister PG, Friedrich N, Watarai A, Hacker MC, Schulz-Siegmund M, Anderegg U. Artificial extracellular matrices support cell growth and matrix synthesis of human dermal fibroblasts in macroporous 3D scaffolds. J Tissue Eng Regen Med 2015; 11:1390-1402. [DOI: 10.1002/term.2037] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2014] [Revised: 01/26/2015] [Accepted: 04/22/2015] [Indexed: 01/10/2023]
Affiliation(s)
- Anja van der Smissen
- Department of Dermatology, Venereology and Allergology; Leipzig University; Germany
- Collaborative Research Centre (SFB-TR67); Matrix Engineering Leipzig and Dresden; Germany
| | - Peter-Georg Hoffmeister
- Pharmaceutical Technology, Institute of Pharmacy; Leipzig University; Germany
- Collaborative Research Centre (SFB-TR67); Matrix Engineering Leipzig and Dresden; Germany
| | - Nadja Friedrich
- Department of Dermatology, Venereology and Allergology; Leipzig University; Germany
- Collaborative Research Centre (SFB-TR67); Matrix Engineering Leipzig and Dresden; Germany
| | - Akira Watarai
- Department of Dermatology, Venereology and Allergology; Leipzig University; Germany
- Collaborative Research Centre (SFB-TR67); Matrix Engineering Leipzig and Dresden; Germany
- School of Medicine; Kitasato University; Japan
| | - Michael C. Hacker
- Pharmaceutical Technology, Institute of Pharmacy; Leipzig University; Germany
- Collaborative Research Centre (SFB-TR67); Matrix Engineering Leipzig and Dresden; Germany
| | - Michaela Schulz-Siegmund
- Pharmaceutical Technology, Institute of Pharmacy; Leipzig University; Germany
- Collaborative Research Centre (SFB-TR67); Matrix Engineering Leipzig and Dresden; Germany
| | - Ulf Anderegg
- Department of Dermatology, Venereology and Allergology; Leipzig University; Germany
- Collaborative Research Centre (SFB-TR67); Matrix Engineering Leipzig and Dresden; Germany
| |
Collapse
|
9
|
Golunova A, Chvátil D, Krist P, Jaroš J, Jurtíková V, Pospíšil J, Kotelnikov I, Abelová L, Kotek J, Sedlačík T, Kučka J, Koubková J, Studenovská H, Streit L, Hampl A, Rypáček F, Proks V. Toward Structured Macroporous Hydrogel Composites: Electron Beam-Initiated Polymerization of Layered Cryogels. Biomacromolecules 2015; 16:1146-56. [DOI: 10.1021/bm501809t] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Affiliation(s)
- Anna Golunova
- Institute
of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square 2, 162 06 Prague 6, Czech Republic
| | - David Chvátil
- Nuclear
Physics Institute, Academy of Sciences of the Czech Republic, Řež
130, 250 68 Řež, Czech Republic
| | - Pavel Krist
- Nuclear
Physics Institute, Academy of Sciences of the Czech Republic, Řež
130, 250 68 Řež, Czech Republic
| | - Josef Jaroš
- Department
of Histology and Embryology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
| | - Veronika Jurtíková
- Department
of Histology and Embryology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
| | - Jakub Pospíšil
- Department
of Histology and Embryology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
| | - Ilya Kotelnikov
- Institute
of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square 2, 162 06 Prague 6, Czech Republic
| | - Lucie Abelová
- Institute
of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square 2, 162 06 Prague 6, Czech Republic
| | - Jiří Kotek
- Institute
of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square 2, 162 06 Prague 6, Czech Republic
| | - Tomáš Sedlačík
- Institute
of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square 2, 162 06 Prague 6, Czech Republic
| | - Jan Kučka
- Institute
of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square 2, 162 06 Prague 6, Czech Republic
- Nuclear
Physics Institute, Academy of Sciences of the Czech Republic, Řež
130, 250 68 Řež, Czech Republic
| | - Jana Koubková
- Institute
of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square 2, 162 06 Prague 6, Czech Republic
| | - Hana Studenovská
- Institute
of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square 2, 162 06 Prague 6, Czech Republic
| | - Libor Streit
- Department
of Plastic and Aesthetic Surgery, St. Anne University Hospital Brno, Pekarska 53, 656 91 Brno, Czech Republic
| | - Aleš Hampl
- Department
of Histology and Embryology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
| | - František Rypáček
- Institute
of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square 2, 162 06 Prague 6, Czech Republic
| | - Vladimír Proks
- Institute
of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square 2, 162 06 Prague 6, Czech Republic
| |
Collapse
|
10
|
Sampathkumar K, Seidi A, Srivastava A, Kumar TS, Ramakrishna S, Ramalingam M. Biomimetic Materials for Engineering Stem Cells and Tissues. Biomimetics (Basel) 2013. [DOI: 10.1002/9781118810408.ch14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
11
|
Tsai WB, Chen YR, Liu HL. RGD-conjugated crosslinked chitosan scaffolds for culture and osteogenic differentiation of mesenchymal stem cells. J Taiwan Inst Chem Eng 2013. [DOI: 10.1016/j.jtice.2012.09.003] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
12
|
|
13
|
Korzhikov VA, Vlakh EG, Tennikova TB. Polymers in orthopedic surgery and tissue engineering: From engineering materials to smart biofunctionalization of a surface. POLYMER SCIENCE SERIES A 2012. [DOI: 10.1134/s0965545x12070036] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
|
14
|
RGD-conjugated UV-crosslinked chitosan scaffolds inoculated with mesenchymal stem cells for bone tissue engineering. Carbohydr Polym 2012; 89:379-87. [DOI: 10.1016/j.carbpol.2012.03.017] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2011] [Revised: 02/28/2012] [Accepted: 03/01/2012] [Indexed: 01/14/2023]
|
15
|
Weber F, Böhme J, Scheidt HA, Gründer W, Rammelt S, Hacker M, Schulz-Siegmund M, Huster D. 31P and 13C solid-state NMR spectroscopy to study collagen synthesis and biomineralization in polymer-based bone implants. NMR IN BIOMEDICINE 2012; 25:464-75. [PMID: 22351643 DOI: 10.1002/nbm.1649] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/02/2010] [Revised: 09/16/2010] [Accepted: 10/31/2010] [Indexed: 05/24/2023]
Abstract
A combination of solid-state NMR spectroscopy and MRI was used to evaluate the formation of extracellular matrix in poly(D,L-lactide-co-glycolide) (PLGA) bone implants. Porous PLGA scaffolds were implanted into rat tibiae and analysed after 2, 4 or 8 weeks. MRI clearly delineated the implants within the cancellous bone. Differences in the trabecular structure of the implanted material and native bone were demonstrated. In addition, implants were analyzed by solid-state NMR spectroscopy under magic angle spinning. (13)C NMR spectra showed the unambiguous signature of collagen formed in the scaffolds, but also the characteristic signals of the PLGA matrix, indicating that resorption was not complete after 8 weeks. Furthermore, (31)P NMR spectroscopy detected the inorganic component of the matrix, which is composed of bioapatite. (31)P NMR spectra were quantified and this analysis revealed that the amount of inorganic extracellular matrix formed de novo was significantly lower than in native bone. This demonstrates that solid-state NMR spectroscopy, in particular in combination with MRI, can provide useful information on the composition and structure of the extracellular matrix, and serve as a tool to evaluate the quality of tissue engineering strategies.
Collapse
Affiliation(s)
- Franziska Weber
- Institute of Medical Physics and Biophysics, University of Leipzig, Leipzig, Germany
| | | | | | | | | | | | | | | |
Collapse
|
16
|
Ambrosch K, Manhardt M, Loth T, Bernhardt R, Schulz-Siegmund M, Hacker MC. Open porous microscaffolds for cellular and tissue engineering by lipid templating. Acta Biomater 2012; 8:1303-15. [PMID: 22155065 DOI: 10.1016/j.actbio.2011.11.020] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2011] [Revised: 10/03/2011] [Accepted: 11/14/2011] [Indexed: 10/15/2022]
Abstract
Porous microspheres fabricated from biodegradable polymers have great potential as microscaffolds in tissue engineering applications, especially for novel strategies such as microtissue fabrication in vitro and microtissue assembly in vivo. Fabrication techniques for microparticulate scaffolds with surface and bulk pore sizes relevant for effective cell intrusion, however, are scarce. This study presents two techniques for the fabrication of open porous microscaffolds from poly(lactide-co-glycolide) in which lipid templating is used for pore formation and combined with either dispersion spraying or a double emulsion technique to determine the size and shape of the particulate structures generated. Both techniques yield microscaffolds with an average size of between 500 and 800 μm, high bulk porosities and open surface pores larger than 50 μm in diameter. Microscaffold morphology was investigated microscopically, particle size distribution was determined and porosity was quantified by intrusion measurements. Particle size and morphology was controlled by the processing parameters and the content and type of lipid porogen. Efficient extraction of the lipid template was shown by thermal analysis. Microscaffold cytocompatibility and in vitro cell culture performance was evaluated with L929 fibroblasts and rat adipose-derived stromal cells (ADSC), respectively. Extracts of different formulations were cytocompatible. Rat ADSC proliferated on the microscaffolds and were differentiated along the adipogenic lineage.
Collapse
|
17
|
Tsai WB, Chen YR, Liu HL, Lai JY. Fabrication of UV-crosslinked chitosan scaffolds with conjugation of RGD peptides for bone tissue engineering. Carbohydr Polym 2011. [DOI: 10.1016/j.carbpol.2011.02.003] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
18
|
Blit PH, Shen YH, Ernsting MJ, Woodhouse KA, Santerre JP. Bioactivation of porous polyurethane scaffolds using fluorinated RGD surface modifiers. J Biomed Mater Res A 2010; 94:1226-35. [PMID: 20694989 DOI: 10.1002/jbm.a.32804] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Biomaterial scaffolds for tissue engineering require appropriate cell adhesion, proliferation, and infiltration into their three-dimensional (3D) porous structures. Surface modification techniques have the potential to enhance cell infiltration into synthetic scaffolds while retaining bulk material properties intact. The objective of this work was to assess the potential of achieving a uniform surface modification in 3D porous constructs through the blending of surface-modifying additives known as bioactive fluorinated surface modifiers (BFSMs) with a base polyurethane material. By coupling RGD peptides to the fluorinated surface modifiers to form RGD-BFSMs, the BFSMs can act as a vehicle for the delivery of RGD moieties to the surface without direct covalent attachment to the polymer substrate. Fluorescent RGD-BFSMs were shown to migrate to the polymer-air interfaces within the porous scaffolds by two-photon confocal microscopy. A-10 rat aortic smooth muscle cells were cultured for 4 weeks on nonmodified and RGD-BFSM-modified porous scaffolds, and cell adhesion, proliferation, and viability were quantified at different depths. RGD-BFSM-modified scaffolds showed significantly greater cell numbers within deeper regions of the scaffolds, and this difference became more pronounced over time. This study demonstrates an effective approach to promote cell adhesion and infiltration within thick (approximately 0.5 cm) porous synthetic scaffolds by providing a uniform distribution of adhesive peptide throughout the scaffolds without the use of covalent surface reaction chemistry.
Collapse
Affiliation(s)
- Patrick H Blit
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
| | | | | | | | | |
Collapse
|
19
|
Tayalia P, Mooney DJ. Controlled growth factor delivery for tissue engineering. ADVANCED MATERIALS (DEERFIELD BEACH, FLA.) 2009; 21:3269-3285. [PMID: 20882497 DOI: 10.1002/adma.200900241] [Citation(s) in RCA: 262] [Impact Index Per Article: 17.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
Growth factors play a crucial role in information transfer between cells and their microenvironment in tissue engineering and regeneration. They initiate their action by binding to specific receptors on the surface of target cells and the chemical identity, concentration, duration, and context of these growth factors contain information that dictates cell fate. Hence, the importance of exogenous delivery of these molecules in tissue engineering is unsurprising, considering their importance for tissue regeneration. However, the short half-lives of growth factors, their relatively large size, slow tissue penetration, and their potential toxicity at high systemic levels, suggest that conventional routes of administration are unlikely to be effective. In this review, we provide an overview of the design criteria for growth factor delivery vehicles with respect to the growth factor itself and the microenvironment for delivery. We discuss various methodologies that could be adopted to achieve this localized delivery, and strategies using polymers as delivery vehicles in particular.
Collapse
|
20
|
MacKinnon N, Guérin G, Liu B, Gradinaru CC, Macdonald PM. Liposome-hydrogel bead complexes prepared via biotin-avidin conjugation. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2009; 25:9413-9423. [PMID: 19603800 DOI: 10.1021/la900163r] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
Liposomes immobilized onto polymeric hydrogel microbeads have potential advantages both in tissue engineering applications and as drug delivery vehicles. Here we demonstrate, quantify, and optimize lipid vesicle binding to polymeric hydrogel microbeads via the avidin-biotin conjugation system and characterize the stability of the resulting microgel-bound liposomes. Microgels consisting of a copolymer of N-isopropylacrylamide (NIPAM) and acrylic acid (AA), cross-linked with bis-acrylamide, that is, p(NIPAM-co-AA), were biotinylated using aqueous carbodiimide chemistry. Extruded liposomes consisting of 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC) plus a small fraction of a biotin-derivatized phosphatidylethanolamine (B-PE) were saturated with avidin and allowed to bind to biotinylated hydrogel beads. Using a combination of fluorescence spectroscopy, quenching, and microscopy and 31P NMR static and magic angle spinning (MAS) spectroscopies, we demonstrate conditions for near-quantitative liposome binding to p(NIPAM-co-AA) microbeads and show that liposome fusion does not occur under such conditions, that the liposomes remain intact and impermeable when so bound, and that they can function as slow release vehicles for entrapped aqueous species.
Collapse
Affiliation(s)
- Neil MacKinnon
- Department of Chemistry, University of Toronto, 80 St. George St., Toronto, Ontario, Canada, M5S 3H6
| | | | | | | | | |
Collapse
|
21
|
Horning JL, Sahoo SK, Vijayaraghavalu S, Dimitrijevic S, Vasir JK, Jain TK, Panda AK, Labhasetwar V. 3-D tumor model for in vitro evaluation of anticancer drugs. Mol Pharm 2008; 5:849-62. [PMID: 18680382 DOI: 10.1021/mp800047v] [Citation(s) in RCA: 219] [Impact Index Per Article: 13.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
The efficacy of potential anticancer drugs during preclinical development is generally tested in vitro using cancer cells grown in monolayer; however, a significant discrepancy in their efficacy is observed when these drugs are evaluated in vivo. This discrepancy, in part, could be due to the three-dimensional (3-D) nature of tumors as compared to the two-dimensional (2-D) nature of monolayer cultures. Therefore, there is a need for an in vitro model that would mimic the 3-D nature of tumors. With this objective, we have developed surface-engineered, large and porous biodegradable polymeric microparticles as a scaffold for 3-D growth of cancer cells. Using the MCF-7 cell line as model breast cancer cells, we evaluated the antiproliferative effect of three anticancer drugs: doxorubicin, paclitaxel and tamoxifen in 3-D model vs in 2-D monolayer. With optimized composition of microparticles and cell culture conditions, a density of 4.5 x 10 (6) MCF-7 cells/mg of microparticles, which is an 18-fold increase from the seeding density, was achieved in six days of culture. Cells were observed to have grown in clumps on the microparticle surface as well as in their interior matrix structure. The antiproliferative effect of the drugs in 3-D model was significantly lower than in 2-D monolayer, which was evident from the 12- to 23-fold differences in their IC 50 values. Using doxorubicin, the flow cytometry data demonstrated approximately 2.6-fold lower drug accumulation in the cells grown in 3-D model than in the cells grown as 2-D monolayer. Further, only 26% of the cells in 3-D model had the same concentration of drug as the cells in monolayer, thus explaining the reduced activity of the drugs in 3-D model. The collagen content of the cells grown in 3-D model was 2-fold greater than that of the cells grown in 2-D, suggesting greater synthesis of extracellular matrix in 3-D model, which acted as a barrier to drug diffusion. The microarray analysis showed changes in several genes in cells grown in 3-D, which could also influence the drug effect. In conclusion, the cells grown in 3-D are more resistant to chemotherapy than those grown in 2-D culture, suggesting the significant roles of cellular architecture, phenotypic variations, and extracellular matrix barrier to drug transport in drug efficacy. We propose that our model provides a better assessment of drug efficacy than the currently used 2-D monolayer as many of its characteristic features are similar to an actual tumor. A well-characterized 3-D model can particularly be useful for rapid screening of a large number of therapeutics for their efficacy during the drug discovery phase.
Collapse
Affiliation(s)
- Jayme L Horning
- Department of Pharmaceutical Sciences, College of Pharmacy, The University of Nebraska Medical Center, Omaha, Nebraska 68198, USA
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Tessmar JK, Göpferich AM. Matrices and scaffolds for protein delivery in tissue engineering. Adv Drug Deliv Rev 2007; 59:274-91. [PMID: 17544542 DOI: 10.1016/j.addr.2007.03.020] [Citation(s) in RCA: 239] [Impact Index Per Article: 14.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2007] [Accepted: 03/28/2007] [Indexed: 11/19/2022]
Abstract
The tissue engineering of functional tissues depends on the development of suitable scaffolds to support three dimensional cell growth. To improve the properties of the scaffolds, many cell carriers serve dual purposes; in addition to providing cell support, cutting-edge scaffolds biologically interact with adhering and invading cells and effectively guide cellular growth and development by releasing bioactive proteins like growth factors and cytokines. To design controlled release systems for certain applications, it is important to understand the basic principles of protein delivery as well as the stability of each applied biomolecule. To illustrate the enormous progress that has been achieved in the important field of controlled release, some of the recently developed cell carriers with controlled release capacity, including both solid scaffolds and hydrogel-derived scaffolds, are described and possible solutions for unresolved issues are illustrated.
Collapse
Affiliation(s)
- Joerg K Tessmar
- Department of Pharmaceutical Technology, University of Regensburg, Regensburg, Germany
| | | |
Collapse
|
23
|
Sokolsky-Papkov M, Agashi K, Olaye A, Shakesheff K, Domb AJ. Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007; 59:187-206. [PMID: 17540473 DOI: 10.1016/j.addr.2007.04.001] [Citation(s) in RCA: 267] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2007] [Accepted: 04/19/2007] [Indexed: 01/18/2023]
Abstract
Growing demand for tissues and organs for transplantation and the inability to meet this need using by autogeneic (from the host) or allogeneic (from the same species) sources has led to the rapid development of tissue engineering as an alternative. Tissue engineering aims to replace or facilitate the regrowth of damaged or diseased tissue by applying a combination of biomaterials, cells and bioactive molecules. This review focuses on synthetic polymers that have been used for tissue growth scaffold fabrication and their applications in both cell and extracellular matrix support and controlling the release of cell growth and differentiation supporting drugs.
Collapse
Affiliation(s)
- Marina Sokolsky-Papkov
- Department of Medicinal Chemistry and Natural Products, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
| | | | | | | | | |
Collapse
|
24
|
Hacker M, Ringhofer M, Appel B, Neubauer M, Vogel T, Young S, Mikos AG, Blunk T, Göpferich A, Schulz MB. Solid lipid templating of macroporous tissue engineering scaffolds. Biomaterials 2007; 28:3497-507. [PMID: 17482257 DOI: 10.1016/j.biomaterials.2007.04.018] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2006] [Accepted: 04/11/2007] [Indexed: 10/23/2022]
Abstract
Macroporous biodegradable cell carriers (scaffolds) provide the three-dimensional matrix for tissue formation in vitro. In this study, we present the fabrication of macroporous scaffolds with high inter-pore connectivity from different biodegradable polymers using the recently developed solid lipid templating technique. Starting from a polymer solution and solid lipid microparticles, a dispersion is prepared and subsequently transferred into molds, which are finally submerged in warm hexane to precipitate the polymer and extract the porogens. The study shows how to control pore structure, pore size and porosity of the scaffold using this technique. The process parameters dispersion viscosity, porogen size and type of polymer are considered. Limits of viscosity are examined by macroscopic and microstructure evaluation of the scaffolds prepared at different viscosities. An approach to rationalize these data by oscillation rheometry is shown. Pore size can be controlled by porogen particle size and adaptation of the viscosity of the polymer solution. Porosity can be modified by changing the ratio of porogen to polymer. The suitability of the resulting scaffolds was shown using an established cartilage cell culture model.
Collapse
Affiliation(s)
- Michael Hacker
- Department of Pharmaceutical Technology, University of Regensburg, Universitätsstrasse 31, 93040 Regensburg, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Tessmar JK, Göpferich AM. Customized PEG-derived copolymers for tissue-engineering applications. Macromol Biosci 2007; 7:23-39. [PMID: 17195277 DOI: 10.1002/mabi.200600096] [Citation(s) in RCA: 160] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
PEG-containing copolymers play a prominent role as biomaterials for different applications ranging from drug delivery to tissue engineering. These custom-designed materials offer enormous possibilities to change the overall characteristics of biomaterials by improving their biocompatibility and solubility, as well as their ability to crystallize in polymer blends and to resist protein adsorption. This article demonstrates various principles of PEG-based material design that are applied to fine tune the properties of biomaterials for different tissue engineering applications. More specifically, strategies are described to develop PEG copolymers with various block compositions and specific bulk properties, including low melting points and improved surface hydrophilicity. Highly hydrated polymer gel networks for promoting cellular growth or suppressing protein adsorption and cell adhesion are introduced. By incorporating selectively cleavable cross-links, these hydrophilic polymers can also serve as smart hydrogel scaffolds, mimicking the natural extracellular matrix for cell cultivation and tissue growth. Ultimately, these developments lead to the creation of biomimetic materials to immobilize bioactive compounds, allowing precise control of cellular adhesion and tissue growth. [image: see text]
Collapse
Affiliation(s)
- Joerg K Tessmar
- Department of Pharmaceutical Technology, University of Regensburg, Universitätsstrasse 31, 93040 Regensburg, Germany.
| | | |
Collapse
|
26
|
Holland TA, Mikos AG. Biodegradable polymeric scaffolds. Improvements in bone tissue engineering through controlled drug delivery. ADVANCES IN BIOCHEMICAL ENGINEERING/BIOTECHNOLOGY 2006; 102:161-85. [PMID: 17089790 DOI: 10.1007/b137205] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Recent advances in biology, medicine, and engineering have led to the discovery of new therapeutic agents and novel materials for the repair of large bone defects caused by trauma, congenital defects, or bone tumors. These repair strategies often utilize degradable polymeric scaffolds for the controlled localized delivery of bioactive molecules to stimulate bone ingrowth as the scaffold degrades. Polymer composition, hydrophobicity, crystallinity, and degradability will affect the rate of drug release from these scaffolds, as well as the rate of tissue ingrowth. Accordingly, this chapter examines the wide range of synthetic degradable polymers utilized for osteogenic drug delivery. Additionally, the therapeutic proteins involved in bone formation and in the stimulation of osteoblasts, osteoclasts, and progenitor cells are reviewed to direct attention to the many critical issues influencing effective scaffold design for bone repair.
Collapse
Affiliation(s)
- Theresa A Holland
- Department of Bioengineering, Rice University, Houston, TX 77251-1892, USA
| | | |
Collapse
|
27
|
Neubauer M, Hacker M, Bauer-Kreisel P, Weiser B, Fischbach C, Schulz MB, Goepferich A, Blunk T. Adipose tissue engineering based on mesenchymal stem cells and basic fibroblast growth factor in vitro. ACTA ACUST UNITED AC 2006; 11:1840-51. [PMID: 16411830 DOI: 10.1089/ten.2005.11.1840] [Citation(s) in RCA: 95] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Despite the clinical need for reconstructive and plastic surgery, the supply of engineered adipose tissue equivalents still remains a challenge. As yet, only preadipocytes have been applied as a cell material for the in vitro tissue engineering of fat. Herein, we report the establishment of a three-dimensional (3-D) long-term cell culture, using bone marrow-derived mesenchymal stem cells (MSCs) as an alternative cell source and custom-made poly(lactic-co-glycolic acid) (PLGA) scaffolds as a cell carrier. Cell-polymer constructs were cultivated for 4 weeks in both the absence and presence of basic fibroblast growth factor (bFGF), which was previously shown to strongly enhance the adipogenesis of MSCs in conventional 2-D short-term culture. A striking enhancement of the adipogenic differentiation of MSCs and tissue development caused by bFGF in the 3-D culture was observed by osmium tetroxide histology and scanning electron microscopy. At the molecular level, reflecting the increased accumulation of lipids, bFGF increased the enzymatic activity of glycerol-3-phosphate dehydrogenase, a late marker of adipogenesis, and the expression of adipocyte-specific genes peroxisome proliferator activated receptor-gamma2 (PPARgamma2) and glucose transporter-4 (GLUT4), as assessed by reverse transcription-polymerase chain reaction. This study demonstrates that the use of bone marrow-derived MSCs, especially in combination with bFGF, may represent a promising approach to adipose tissue engineering.
Collapse
Affiliation(s)
- Markus Neubauer
- Department of Pharmaceutical Technology, University of Regensburg, Regensburg, Germany
| | | | | | | | | | | | | | | |
Collapse
|
28
|
Ho MH, Wang DM, Hsieh HJ, Liu HC, Hsien TY, Lai JY, Hou LT. Preparation and characterization of RGD-immobilized chitosan scaffolds. Biomaterials 2005; 26:3197-206. [PMID: 15603814 DOI: 10.1016/j.biomaterials.2004.08.032] [Citation(s) in RCA: 150] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2004] [Accepted: 08/31/2004] [Indexed: 10/26/2022]
Abstract
Chitosan scaffolds were modified with RGDS (Arg-Gly-Asp-Ser) in the present work via an imide-bond forming reaction between amino groups in chitosan and carboxyl groups in peptides. Successful immobilization was verified with FTIR spectroscopy, and the immobilized amount was determined to be on the order of 10(-12) mol/cm2 through analysis of the immobilized amino acids. Results of experiments of cell culture with rat osteosarcoma (ROS) cells demonstrated that RGDS immobilization could enhance the attachment of ROS cells onto the chitosan, resulting in higher cell density attached to the RGDS-modified scaffold than to the unmodified scaffold. It should be noted that only RGDS, but not other peptide such as RGES, is effective in enhancing cell attachment and possible proliferation. Experiments of in vitro mineralization indicated that there were more cells on the RGDS-modified scaffold than on the unmodified scaffold, which tended to form bone-like tissues. The results presented in this work suggest that immobilization of RGDS can make chitosan scaffolds more compatible for the culture of osteoblast-like cells and the regeneration of bone-like tissues.
Collapse
Affiliation(s)
- Ming-Hua Ho
- Department of Chemical Engineering, National Taiwan University, Taipei, Taiwan
| | | | | | | | | | | | | |
Collapse
|
29
|
Lieb E, Hacker M, Tessmar J, Kunz-Schughart LA, Fiedler J, Dahmen C, Hersel U, Kessler H, Schulz MB, Göpferich A. Mediating specific cell adhesion to low-adhesive diblock copolymers by instant modification with cyclic RGD peptides. Biomaterials 2005; 26:2333-41. [PMID: 15585236 DOI: 10.1016/j.biomaterials.2004.07.010] [Citation(s) in RCA: 61] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2004] [Accepted: 07/22/2004] [Indexed: 11/23/2022]
Abstract
One promising strategy to control the interactions between biomaterial surfaces and attaching cells involves the covalent grafting of adhesion peptides to polymers on which protein adsorption, which mediates unspecific cell adhesion, is essentially suppressed. This study demonstrates a surface modification concept for the covalent anchoring of RGD peptides to reactive diblock copolymers based on monoamine poly(ethylene glycol)-block-poly(D,L-lactic acid) (H(2)N-PEG-PLA). Films of both the amine-reactive (ST-NH-PEG(2)PLA(20)) and the thiol-reactive derivative (MP-NH-PEG(2)PLA(40)) were modified with cyclic alphavbeta3/alphavbeta5 integrin subtype specific RGD peptides simply by incubation of the films with buffered solutions of the peptides. Human osteoblasts known to express these integrins were used to determine cell-polymer interactions. The adhesion experiments revealed significantly increased cell numbers and cell spreading on the RGD-modified surfaces mediated by RGD-integrin-interactions.
Collapse
Affiliation(s)
- E Lieb
- Department of Pharmaceutical Technology, University of Regensburg, Universitaetsstrasse 31, 93040 Regensburg, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Kidane AG, Salacinski H, Tiwari A, Bruckdorfer KR, Seifalian AM. Anticoagulant and antiplatelet agents: their clinical and device application(s) together with usages to engineer surfaces. Biomacromolecules 2005; 5:798-813. [PMID: 15132664 DOI: 10.1021/bm0344553] [Citation(s) in RCA: 109] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
An essential aspect of the treatment of patients with cardiovascular disease is the use of anticoagulant and antiplatelet agents for the prevention of further ischaemic events and vascular death resulting from thrombosis. Aspirin and heparin have been the standard therapy for the management of such conditions to date. Recently, numerous more potent platelet inhibitors together with anticoagulant agents have been developed and tested in randomized clinical trials. This article reviews the current state of the art of antiplatelet and anticoagulant therapy in light of its potential clinical efficacy. It then focuses on the usages of these agents in order to improve the performance of clinical devices such as balloon catheters, coronary stents, and femoropopliteal bypass grafting and extra corporeal circuits for cardiopulmonary bypass. The article then goes on to look at the usage of these agents more specifically heparin, heparan, hirudin, and coumarin in the development of more biocompatible scaffolds for tissue engineering.
Collapse
Affiliation(s)
- Asmeret G Kidane
- University Department of Surgery, Royal Free and University College Medical School, University College London, Royal Free Hospital, London NW3 2QG, United Kingdom
| | | | | | | | | |
Collapse
|
31
|
Fischbach C, Seufert J, Staiger H, Hacker M, Neubauer M, Göpferich A, Blunk T. Three-dimensional in vitro model of adipogenesis: comparison of culture conditions. ACTA ACUST UNITED AC 2004; 10:215-29. [PMID: 15009947 DOI: 10.1089/107632704322791862] [Citation(s) in RCA: 51] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
In vivo and in vitro studies have demonstrated both promise and current limitations in tissue engineering of fat. Herein, we report the establishment of a well-defined three-dimensional (3-D) in vitro model useful for systematic investigations of 3-D adipogenesis. Polyglycolic acid fiber meshes were dynamically seeded with 3T3-L1 preadipocytes; subsequently, cell-polymer constructs were hormonally induced and cultivation under three different conditions was evaluated. Regarding tissue coherence and intracellular lipid content, culture of cell-polymer constructs either dynamically in well plates or in stirred bioreactors yielded similar results, which were distinctly improved compared with static conditions in well plates. At the protein and mRNA levels, significantly increased expression of genes characteristic for a mature adipose phenotype was demonstrated for constructs dynamically cultured in well plates, as compared with static conditions. Furthermore, investigation of lipolysis under stimulating and inhibiting conditions demonstrated functionality of the dynamically differentiated constructs. Using dynamic culture conditions, the presented in vitro model system is suggested as a valuable tool serving both fat tissue engineering and basic research by facilitating investigations of tissue-inherent features not possible under conventional 2-D culture conditions.
Collapse
Affiliation(s)
- Claudia Fischbach
- Department of Pharmaceutical Technology, University of Regensburg, Regensburg, Germany
| | | | | | | | | | | | | |
Collapse
|
32
|
Drotleff S, Lungwitz U, Breunig M, Dennis A, Blunk T, Tessmar J, Göpferich A. Biomimetic polymers in pharmaceutical and biomedical sciences. Eur J Pharm Biopharm 2004; 58:385-407. [PMID: 15296963 DOI: 10.1016/j.ejpb.2004.03.018] [Citation(s) in RCA: 100] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2004] [Accepted: 03/05/2004] [Indexed: 10/26/2022]
Abstract
This review describes recent developments in the emerging field of biomimetic polymeric biomaterials, which signal to cells via biologically active entities. The described biological effects are, in contrast to many other known interactions, receptor mediated and therefore very specific for certain cell types. As an introduction into this field, first some biological principles are illustrated such as cell attachment, cytokine signaling and endocytosis, which are some of the mechanisms used to control cells with biomimetic polymers. The next topics are then the basic design rules for the creation of biomimetic materials. Here, the major emphasis is on polymers that are assembled in separate building blocks, meaning that the biologically active entity is attached to the polymer in a separate chemical reaction. In that respect, first individual chemical standard reactions that may be used for this step are briefly reviewed. In the following chapter, the emphasis is on polymer types that have been used for the development of several biomimetic materials. There is, thereby, a delineation made between materials that are processed to devices exceeding cellular dimensions and materials predominantly used for the assembly of nanostructures. Finally, we give a few current examples for applications in which biomimetic polymers have been applied to achieve a better biomaterial performance.
Collapse
Affiliation(s)
- S Drotleff
- Department of Pharmaceutical Technology, University of Regensburg, Regensburg, Germany
| | | | | | | | | | | | | |
Collapse
|